Bioasis Technologies Inc. announced that its board of directors has appointed Dr. Deborah A. Rathjen as president and chief executive officer. Dr. Rathjen, who is a member of the board of directors and has served as executive chair since December 10, 2018, replaces Dr. Mark Day, who has left the company, effective immediately. Deborah has significant experience in company building and financing, mergers and acquisitions, therapeutic product research and development, business development, licensing and commercialization.